EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections

Metin Yıldırım, Nejat Düzgüneş iD

Antibiotics · 20.07.2025 · 14 (7) · 728

DOI: 10.3390/antibiotics14070728 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 20.07.2025. Verfasst von Metin Yıldırım und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Harran University, Şanlıurfa 63000, Türkiye. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

About a quarter of the world’s population is infected with Mycobacterium tuberculosis. Growing antibiotic resistance by this microorganism is a major problem in the therapy of the disease. M. avium-M. intracellulare that emerged as a major opportunistic infection of HIV/AIDS continues to afflict immunocompromised individuals. We describe the use of liposome-encapsulated antibiotics in the experimental and clinical therapy of mycobacterial infections, as well as recent experimental liposomal vaccines against tuberculosis. Liposome-mediated intravenous or inhalational delivery of antibiotics enhances the antibacterial effects of the drugs, particularly for infections of resident macrophages, where the liposomes are passively targeted. Despite experimental successes of liposomal antibiotics in the treatment of mycobacterial and other bacterial infections, applications of this method to the clinic have been lagging. This review underscores the significance of liposomes in the treatment of mycobacterial infections, encompassing their synthesis methods, limitations, and both preclinical and clinical studies, providing guidance for the development of future therapeutic approaches and innovative antimicrobial strategies.

Schlagwörter

Stichwörter der Autor:innen

antibioticsantimycobacterial agentsbacterial infectionsliposomestuberculosistuberculosis vaccines

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Harran University, Şanlıurfa 63000, Türkiye.
  • Department of Biomedical Sciences, Arthur A. Dugoni School of Dentistry, University of the Pacific, 155 Fifth Street, Francisco, CA 94103, USA.

ORCID-Profile: Nejat Düzgüneş

Zitieren

APA

Yıldırım, M., & Düzgüneş, N. (2025). Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections. Antibiotics, 14(7), 728. https://doi.org/10.3390/antibiotics14070728

Vancouver

Yıldırım M, Düzgüneş N. Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections. Antibiotics. 2025;14(7):728. doi:10.3390/antibiotics14070728

BibTeX
@article{Yldrm2025,
  author = {Yıldırım, Metin and Düzgüneş, Nejat},
  title = {Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {7},
  pages = {728},
  doi = {10.3390/antibiotics14070728}
}
Kostenlos starten →